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Abstract 
 In this study we have investigated the electroencephalogram (EEG) background 
activity in patients with Alzheimer’s disease (AD) using non-linear analysis methods. We 
calculated the Lempel-Ziv (LZ) complexity – applying two different sequence conversion 
methods – and the Central Tendency Measure (CTM) of the EEG in 11 AD patients and 11 
age-matched control subjects. CTM quantifies the degree of variability, while LZ complexity 
reflects the arising rate of new patterns along with the EEG time series. We did not find 
significant differences between AD patients and control subjects’ EEGs with CTM. On the 
other hand, AD patients had significantly lower LZ complexity values (p < 0.01) at electrodes 
P3 and O1 with a two symbol sequence conversion, and P3, P4, O1 and T5 using three 
symbols. Our results show a decreased complexity of EEG patterns in AD patients. In 
addition, we obtained 90.9% sensitivity and 72.7% specificity at O1, and 72.7% sensitivity 
and 90.9% specificity at P3 and P4. These findings suggest that LZ complexity may contribute 
to increase the insight into brain dysfunction in AD in ways which are not possible with more 
classical and conventional statistical methods. 
 
Keywords: Alzheimer’s disease; EEG; Non-linear dynamics; Lempel-Ziv Complexity; Central 
Tendency Measure. 
 
 3 
1. Introduction 
 Alzheimer's disease (AD) is the most common neurodegenerative disease and is 
considered to be the main cause of dementia in western countries [1]. AD is characterized by 
progressive impairments in cognition and memory whose course lasts several years prior to 
death. These clinical features are accompanied by characteristic histological changes in the 
brain. They include diffuse atrophy of the cortex and microscopical neuritic plaques 
(containing amyloid Aβ), neurofibrillary tangles and deposits of amyloid in the walls of the 
brain arteries. Although a definite diagnosis is only possible by necropsy, a differential 
diagnosis with other types of dementia and with major depression should be attempted. 
Magnetic resonance imaging and computerized tomography can be normal in the early stages 
of AD but a diffuse cortical atrophy is the main sign in brain scans. Mental status tests are 
also useful. 
 The electroencephalogram (EEG) has been used as a tool for diagnosing dementias for 
several decades. Typical EEG abnormalities in AD are characterized by a diffuse slowing of 
the background activity [2], namely through an increase in delta and theta activity along with 
a decrease in alpha activity, and a decreased coherence among cortical areas [3], although in 
the early stages of the disease the EEG may exhibit normal frequencies.  
 Recent progress in the theory of non-linear dynamics has provided new methods for 
the study of the EEG [4]. Non-linearity in the brain is introduced even at the cellular level, 
since the dynamical behaviour of individual neurons is governed by threshold and saturation 
phenomena. Moreover, the hypothesis of an entirely stochastic brain can be rejected due to its 
ability to perform sophisticated cognitive tasks. Considering this, non-linear dynamical 
analysis techniques may be a better approach than traditional linear methods to obtain a better 
understanding of abnormal dynamics in EEG signals [5,6]. 
 Many studies are known in which non-linear time series analysis techniques were 
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applied to EEGs. Correlation dimension (D2), a measure of system dimensional complexity 
[7], has been extensively investigated in EEG studies of different physiological and 
pathological states [8-13]. Particularly, several studies have examined the D2 in AD. The idea 
behind them is that the loss of neurons and synapses results in less complex dynamics of 
neural networks and, consequently, reduced D2 values [14]. It has been found that AD 
patients have lower D2 values than controls [10,15-17]. These results show a decrease in the 
complexity of the electrical activity in brains injured by AD [4]. 
 The Lyapunov exponents have also traditionally been used to characterize non-linear 
behaviour: if the first Lyapunov exponent (L1) is positive, the system is “chaotic” [18]. L1 
reflects the “unpredictability” of the underlying system and has been applied in EEG analysis 
to study the changes in normal brain development [19]. Moreover, it has been shown that AD 
patients have significantly lower L1 values than controls in almost all EEG channels [16,17]. 
The decrease of L1 in the EEG of AD patients reflects a drop in the flexibility of information 
processing in the injured brain [16]. 
 Nevertheless, the amount of data required for meaningful results in the computation of 
D2 and Lyapunov exponents is beyond the experimental possibilities for physiological data 
[20]. Moreover, the algorithms used to estimate the D2 assume the time series to be stationary, 
something generally not true with biological data. Therefore, it becomes necessary to apply 
other non-linear methods to study the EEG background activity. For instance, non-linear 
forecasting and entropy maps have been used to characterize drug effects on brain dynamics 
in AD [21] and mutual information analysis to assess information transmission between 
different cortical areas in AD [22]. More recently, Pijnenburg et al. [23] have found a 
decrease of beta band synchronization likelihood both in a resting condition and during a 
working memory task in AD.  
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In the present study, we have examined the EEG background activity in AD patients 
with two non-linear methods: Lempel-Ziv (LZ) complexity and computation of the Central 
Tendency Measure (CTM) from scatter plots of first differences of the data. We wanted to test 
the hypothesis that the AD patients’ EEG might be characterized by an abnormal type of 
dynamics. The LZ complexity [24] is a nonparametric measure of complexity in a one-
dimensional signal related to the number of distinct substrings and the rate of their recurrence. 
CTM is a non-linear approach using continuous chaotic modelling that summarizes the degree 
of variability in a signal [25]. 
The paper is organized as follows. In Section 2 we explain the selection of patients and 
controls, and the procedure for recording the EEG and selecting artefact-free epochs. LZ 
complexity, CTM and the statistical tools used to evaluate the differences between AD 
patients and control subjects are also introduced in Section 2. Section 3 presents the results of 
our study. Finally, in Section 4 we discuss our results and compare them with other studies of 
the EEG background activity in AD patients with non-linear analysis methods, and we draw 
our conclusions. 
 
2. Methods 
2.1. Selection of patients and controls 
 We studied 11 patients (5 men and 6 women; age = 72.5 ± 8.3 years, mean ± standard 
deviation SD) fulfilling the criteria of probable AD. The patients were recruited from the 
Alzheimer’s Patients’ Relatives Association of Valladolid (AFAVA) and referred to the 
University Hospital of Valladolid (Spain), where the EEG was recorded. All of them had 
undergone a thorough clinical evaluation that included clinical history, physical and 
neurological examinations, brain scans and a Mini-Mental State Examination (MMSE), 
generally accepted as a quick and simple way to evaluate cognitive function [26]. Five 
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patients had a MMSE score of less than 12 points, indicating a severe degree of dementia. The 
mean MMSE score for the patients was 13.1 ± 5.9 (Mean ± SD). Two subjects were receiving 
lorapezam. With therapeutic doses, benzodiapzepines may enhance beta activity, although no 
prominent rapid rhythms were observed in the visual examination of these two subjects’ 
EEGs. None of the other patients used medication that could be expected to influence the 
EEG. 
 The control group consisted of 11 age-matched, elderly control subjects without past 
or present neurological disorders (7 men and 4 women; age = 72.8 ± 6.1 years, mean ± SD). 
The MMSE score value for all control subjects was 30. 
 The local ethics committee approved the study. All control subjects and all caregivers 
of the demented patients gave their informed consent for participation in the current study. An 
EEG was recorded from all patients and controls. 
 
2.2. EEG recording 
 The EEGs were recorded from the 19 scalp loci of the international 10-20 system 
(channels Fp1, Fp2, F3, F4, C3, C4, P3, P4, O1, O2, F7, F8, T3, T4, T5, T6, Fz, Cz and Pz), 
with all electrodes referenced to the chin. Recordings were made with the subjects in a 
relaxed state and under the eyes-closed condition in order to obtain as many artefact-free EEG 
data as possible. More than five minutes of data were recorded from each subject using a 
Profile Study Room 2.3.411 EEG equipment (Oxford Instruments). Data were first processed 
with a low-pass hardware filter at 100 Hz, then they were sampled at 256 Hz and digitised by 
a 12-bit analogue-digital converter.  
 The recordings were visually inspected by a specialist physician to reject artefacts. 
Thus, only EEG data free from electrooculographic and movement artefacts, and with 
minimal electromyographic (EMG) activity were selected. Afterwards, EEGs were organized 
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in 5 second artefact-free epochs (1280 points) that were copied as ASCII files for off-line 
analysis on a personal computer. An average number of 30.0 ± 12.5 artefact-free epochs 
(Mean ± SD) were selected from each electrode for each subject.  
 In order to remove the residual EMG activity and the noise owing to the electrical 
mains, all selected epochs were digitally filtered prior to the non-linear analysis. We used a 
Hamming window FIR band-pass filter with cut-off frequencies at 0.5 Hz and at 40 Hz 
designed with Matlab®. 
 
2.3. Central Tendency Measure 
 Chaotic equations are sometimes used to generate graphs. We can produce scatter 
plots of first differences of the data which graph x(n+2)-x(n+1) versus x(n+1)-x(n), where 
each x(n) is the value of the EEG time series at time n. These plots, centred around the origin, 
give a graphical representation of the degree of variability in the time series and are useful in 
modelling biological systems such as hemodynamics and heart rate variability [25]. With this 
approach, rather than defining a time series as chaotic or not chaotic, the degree of variability 
or chaos is evaluated.  
 To quantify this level of variability, the central tendency measure (CTM) has been 
used [25]. CTM is computed from the scatter plots of first differences of the data selecting a 
circular region of radius ρ around the origin, counting the number of points that fall within the 
radius, and dividing by the total number of points. A low CTM value indicates a large amount 
of dispersion and a high value concentration near the centre. Given N data points from a time 
series, N-2 would be the total number of points in the scatter plot. Then, the CTM can be 
computed as [25], 
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 The application of this approach to a classification problem involving the separation of 
congestive heart failure patients from normal individuals analysing R-R intervals from Holter 
tapes shows promise [25]. Preliminary studies indicate that the method can be adapted to 
determine the clinical significance of the variability findings in more complex time series 
such as the EEG [27]. Moreover, the combination of CTM analysis of the EEG, clinical 
parameters and neuropsychological testing can be useful in the diagnosis of AD [28] and in 
the differentiation among types of dementia [29]. 
 Although the radius is critical in determining the outcome of CTM, no guidelines exist 
for optimising its value. Hence, it is usually chosen depending upon the character of the data. 
We have developed a new method to select the radius ρ. First, we compute the CTM with 
several radii. Then, we apply a one-way ANOVA test to compare the CTM results of both 
groups and we estimate the p value for each of the radii. The selected radius is that for which 
we obtain the lowest p value in the comparison between both groups. In this study we have 
computed the CTM with ρ = 2. 
 
2.4. Lempel-Ziv Complexity 
The Lempel-Ziv (LZ) complexity for sequences of finite length was suggested by 
Lempel and Ziv [24]. It is a nonparametric, simple-to-calculate measure of complexity in a 
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one-dimensional signal that does not require long data segments to compute [30]. LZ 
complexity is related to the number of distinct substrings and the rate of their recurrence 
along the given sequence [31], with larger values corresponding to more complexity in the 
data. It has been applied to study the brain function [32], brain information transmission [33] 
and to detect ventricular tachychardia and fibrillation [30]. Preliminary evidence suggests 
that, applied to EEGs, LZ complexity is predictive of epileptic seizures [31] and can be useful 
to quantify the depth of anaesthesia [6,34]. Moreover, it has been applied to extract 
complexity from mutual information time series of EEGs in order to predict response during 
isoflurane anaesthesia with artificial neural networks [35]. 
 LZ complexity analysis is based on a coarse-graining of the measurements, so before 
calculating the complexity measure c(n), the signal must be transformed into a finite symbol 
sequence. In this study we have used two different sequence conversion methods: 
a) 0-1 sequence conversion. The median value is estimated as a threshold Td, as 
partitioning about the median is robust to outliers [36]. By comparison with the 
threshold, the signal data are converted into a 0-1 sequence P = s(1), s(2),…, s(n), with 
s(i) defined by [6]: 
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xmax and minimum xmin are calculated. Two thresholds are obtained: Td1 = xm – |xmin|/16 
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The sequence P is scanned from left to right for both conversion methods and the 
complexity counter c(n) is increased by one unit every time a new subsequence of consecutive 
characters is encountered. The complexity measure can be estimated using the following 
algorithm [6,30,34]: 
1. Let S and Q denote two subsequences of P and SQ be the concatenation of S and 
Q, while sequence SQpi is derived from SQ after its last character is deleted (pi 
means the operation to delete the last character in the sequence). Let v(SQpi) 
denote the vocabulary of all different subsequences of SQpi. At the beginning, c(n) 
= 1, S = s(1), Q = s(2), therefore, SQpi = s(1). 
2. In general, S = s(1), s(2),…, s(r), Q = s(r+1), then SQpi = s(1), s(2),…, s(r); if Q 
belongs to v(SQpi), then Q is a subsequence of SQpi, not a new sequence. 
3. Renew Q to be s(r+1), s(r+2) and judge if Q belongs to v(SQpi) or not. 
4. Repeat the previous steps until Q does not belong to v(SQpi). Now Q = s(r+1), 
s(r+2),…, s(r+i) is not a subsequence of SQpi = s(1), s(2),…, s(r+i-1), so increase 
c(n) by one. 
5. Thereafter, S is renewed to be S = s(1), s(2),…, s(r+i), and Q = s(r+i+1). 
These procedures have to be repeated until Q is the last character. At this time the 
number of different subsequences in P – the measure of complexity – is c(n). 
 In order to obtain a complexity measure which is independent of the sequence length, 
c(n) should be normalized. If the length of the sequence is n and the number of different 
symbols in the symbol set is α, it has been proved [24] that the upper bound of c(n) is given 
by: 
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where εn is a small quantity and εn → 0 (n → ∞). In general, n/logα(n) is the upper bound of 
c(n), where the base of the logarithm is α, i.e., 
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and c(n) can be normalized via b(n): 
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C(n), the normalized LZ complexity, reflects the arising rate of new patterns along with the 
sequence. Thus, it captures the temporal structure of the sequence. 
 
2.5. Statistical analysis 
 One-way ANOVA tests were used to evaluate the statistical differences between the 
estimated LZ complexity and CTM values for AD patients and control subjects. If significant 
differences between groups were found, the ability of the non-linear analysis method to 
discriminate AD patients from control subjects was evaluated using Receiver Operating 
Characteristic (ROC) plots [37]. 
 ROC plots can be obtained by plotting the sensitivity values (the proportion of patients 
with a diagnosis of AD who test positive) on the y axis against their equivalent (1-specificity) 
values (specificity represents the percentage of controls correctly recognized) for all the 
available cut-off points (in this case, the non-linear analysis method values) on the x axis.
 Accuracy is a related parameter that quantifies the total number of subjects (AD 
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patients and control subjects) precisely classified. The optimum threshold is the cut-off point 
in which the highest accuracy (minimal false negative and false positive results) is obtained. It 
can be determined from the ROC curve as the closest value to the left top point (100% 
sensitivity, 100% specificity). 
 Figure 1 shows a block diagram with the different steps followed in this study. 
------------------------------------------------------------ 
Insert figure 1 around here 
------------------------------------------------------------ 
 
3. Results 
 LZ complexity and CTM were estimated for channels Fp1, Fp2, F3, F4, C3, C4, P3, 
P4, O1, O2, F7, F8, T3, T4, T5 and T6. The results have been averaged based on all the 
artefact-free 5 second epochs (N=1280 points) within the five-minute period of EEG 
recordings. 
 The CTM values (Mean ± SD) for the AD patients and control subjects and the 
corresponding p-values are summarized in Table 1. No significant differences were found 
between both groups (p > 0.01). 
------------------------------------------------------------ 
Insert Table 1 around here 
------------------------------------------------------------ 
 The average LZ complexity values and standard deviations for the AD patients and 
normal control subjects for the 16 electrodes are summarized in Table 2 (0-1 sequence 
conversion) and Table 3 (0-1-2 sequence conversion). The AD patients have significantly 
lower LZ complexity values (p < 0.01) at electrodes P3 and O1 for the two symbol sequence 
conversion, and electrodes P3, P4, O1 and T5 for the three symbol sequence conversion. 
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These results suggest that EEG activity of AD patients is less complex in certain regions than 
in a normal brain. 
------------------------------------------------------------ 
Insert Tables 2 and 3 around here 
------------------------------------------------------------ 
 Finally, we evaluated the ability of the LZ complexity to discriminate AD patients 
from control subjects with both sequence conversions at the electrodes in which significant 
differences were found using ROC plots [37]. Table 4 summarizes the results.  
------------------------------------------------------------ 
Insert table 4 around here 
------------------------------------------------------------ 
 The value for the area under the ROC curve can be interpreted as follows: an area of 
0.893 (electrode P3 with 0-1-2 sequence conversion, for example) means that a randomly 
selected individual from the control subjects’ group has a LZ complexity value larger than that 
of a randomly chosen individual from the AD patients’ group in 89.3% of the time [37]. A 
rough guide to classify the precision of a diagnostic test is related to the area under the ROC 
curve. With values between 0.90 and 1 the precision of the diagnostic test is considered to be 
excellent, good for values between 0.80 and 0.90, fair if the results are in the range 0.70-0.79, 
poor when the value of the area under the ROC curve is between 0.60 and 0.69, and bad for 
values between 0.50 and 0.59. Thus, the results obtained with LZ complexity and both 
sequence conversion methods can be considered good. 
 With the 0-1 sequence conversion the highest sensitivity was obtained at O1 (90.9%) 
and the highest specificity at P3 (90.9%). The accuracy of the diagnostic test was similar at 
both electrodes (81.8%). Figure 2 shows the ROC curves for both electrodes. 
------------------------------------------------------------ 
 14 
Insert figure 2 around here 
------------------------------------------------------------ 
 Using a three symbol sequence conversion we obtained the highest specificity at P4 
(90.9%), while the highest sensitivity was obtained at O1 (90.9%). The accuracy was 81.8% 
at P3, P4 and O1. Figure 3 shows the ROC curves for all the electrodes in which the 
differences between both groups were significant with the 0-1-2 sequence conversion. 
------------------------------------------------------------ 
Insert figure 3 around here 
------------------------------------------------------------ 
 
4. Discussion 
 In this pilot study we have analysed the EEG background activity of 11 control 
subjects and 11 patients with AD applying two non-linear methods: Lempel-Ziv (LZ) 
complexity and computation of the Central Tendency Measure (CTM) from scatter plots of 
first differences of the data. 
 The CTM method has proven not to be effective in discriminating AD patients from 
control subjects. We have not found relevant differences between the degree of variability 
from scatter plots of first differences of the EEG time series from both groups. However, our 
findings differ from other studies – with very small sample sizes – showing that the 
combination of CTM analysis of the EEG, clinical parameters and neuropsychological testing 
can be useful in the diagnosis of dementia [28,29]. Thus, the possible usefulness of CTM in 
the diagnosis of AD should be investigated with a larger number of patients and control 
subjects. 
 On the other hand, our results show that AD patients have significantly lower LZ 
complexity values (p < 0.01) at electrodes P3 and O1 when we employed a two symbol 
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sequence conversion. Moreover, using a three symbol sequence conversion we found a 
significantly reduced LZ complexity (p < 0.01) at electrodes P3, P4, O1 and T5 in AD 
patients. Although previous studies claimed that a two symbol sequence conversion was 
enough to study the dynamic complexity of a system [31-33], our results suggest that a three 
symbol conversion might give more detailed insight of the differences between the AD 
patients and control subjects’ EEGs. This may be due to the fact that a 0-1-2 conversion can 
keep more information of the EEG during the coarse-graining process. Furthermore, we 
compared our LZ complexity results by means of sensitivity, specificity and accuracy with a 
selected threshold to improve the sensitivity/specificity pair according to ROC plots [37]. For 
both sequence conversion methods the highest sensitivity was obtained at electrode O1 
(90.9%), while the specificity improved in the parietal region (90.9% at electrode P3 with a 0-
1 sequence conversion and at electrode P4 with a 0-1-2 sequence conversion). 
 A larger value of LZ complexity means that the chance of new pattern generation is 
greater, so the sequence is more complex, and vice versa. We infer that brains affected by AD 
show a less complex electrophysiological behaviour, specially in the left parietal and occipital 
regions. Our results agree with findings showing that the EEG of AD patients has lower D2 
values than that of control subjects [14,16,17]. In non-linear EEG analysis, D2 is considered to 
be a reflection of the complexity of the cortical dynamics underlying EEG recordings. Thus, 
reduced D2 values exhibit a decrease in the complexity of brain electrical activity. 
Furthermore, Besthorn et al. [38] found that a lower D2 was correlated with increased severity 
of dementia and that this method correctly classified AD patients and controls with an 
accuracy of 70% [39]. Pritchard et al. [15] showed that the addition of non-linear measures 
(D2) and a neural net classification procedure to linear methods improves the classification 
accuracy of the AD/control status of subjects up to 92%. The decreased complexity of brain 
activity in AD patients has also been shown using L1 [16,17]. The L1 of the EEG can be 
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interpreted as a measure of flexibility of information processing in the brain [40]. Thus, the 
decreased L1 values in AD patients reflect a drop in the flexibility of information processing 
in the injured brain [16,17]. 
 However, the neurophysiological implications of the decreased EEG complexity in 
AD patients are not clear [4]. Among others, three mechanisms can be responsible for this 
decrease in dynamical complexity: neuronal death, a general effect of neurotransmitter 
deficiency and loss of connectivity of local neural networks as a result of nerve cell death 
[4,14]. The reduction of the LZ complexity in the EEG of AD patients may be interpreted as 
“decomplexification” associated with the inactivation of previously active neural networks.  
 One important feature of LZ complexity is model-independence. Only those 
differences between activity patterns that make a difference to the underlying system itself are 
considered, no matter whether the system is dominated by deterministic chaos or a stochastic 
process [6]. While applying this non-linear method to the EEG, we are not testing for a 
particular model form, but attempting to distinguish among the EEG data sets of AD patients 
and control subjects on the basis of complexity. Moreover, LZ complexity is a more precise 
measure than L1 for characterizing order or disorder [41] and is better suited for EEG analysis 
than D2 [6]. The use of this quantitative complexity measure can help us gain a better insight 
into the system dynamics [6]. 
 Some limitations of our study merit consideration. First of all, the sample size was 
small. As a result, our findings are preliminary and require replication in a larger patient 
population before any conclusion can be made of its clinical diagnostic value. Moreover, the 
detected decrease of EEG complexity is not specific to AD. It appears in several physiological 
and pathological states, including anaesthesia [6], schizophrenia [11], vascular dementia [17] 
and during seizure activity in epilepsy [31,42]. Ageing and age-related diseases often 
accompany a wide-ranging loss of physiological complexity [43]. Thus, although LZ 
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complexity might be a helpful tool for recognition of AD, further work must be carried out to 
examine non-linear EEG activity in other types of dementia. 
  In summary, although non-linear EEG analysis cannot yet be applied as a diagnostic 
tool, our findings show the possibility to analyse the dynamical behaviour of the brain in AD 
patients with LZ complexity. Non-linear dynamics suggest that AD can be a dynamical 
disease which is characterized by changes in the qualitative dynamics of physiological 
processes [4]. We expect that non-linear analysis will give us a deeper understanding of the 
brain function in ways which are not possible with more classical and conventional statistical 
methods. 
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Tables 
Table 1 
The average CTM values of the EEGs for the AD patients and control subjects for all 
channels. 
Electrode AD patients (Mean ± SD) 
Control subjects 
(Mean ± SD) 
Statistical analysis 
p value 
F3 0.52 ± 0.16 0.63 ± 0.14 0.1050 
F4 0.54 ± 0.15 0.63 ± 0.15 0.1747 
F7 0.31 ± 0.10 0.44 ± 0.14 0.0205 
F8 0.33 ± 0.14 0.45 ± 0.14 0.0795 
Fp1 0.40 ± 0.17 0.50 ± 0.14 0.1623 
Fp2 0.41 ± 0.15 0.50 ± 0.18 0.1834 
T3 0.23 ± 0.12 0.31 ± 0.17 0.2036 
T4 0.21 ± 0.11 0.35 ± 0.17 0.0336 
T5 0.41 ± 0.08 0.38 ± 0.19 0.6844 
T6 0.40 ± 0.13 0.36 ± 0.16 0.5182 
C3 0.61 ± 0.19 0.69 ± 0.17 0.2898 
C4 0.58 ± 0.19 0.67 ± 0.18 0.2746 
P3 0.57 ± 0.15 0.55 ± 0.21 0.7932 
P4 0.57 ± 0.14 0.53 ± 0.20 0.6001 
O1 0.40 ± 0.10 0.33 ± 0.18 0.2097 
O2 0.41 ± 0.10 0.32 ± 0.16 0.1224 
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Table 2 
The average LZ Complexity (0-1 sequence conversion) values of the EEGs for the AD 
patients and control subjects for all channels.  
Electrode AD patients (Mean ± SD) 
Control subjects 
(Mean ± SD) 
Statistical analysis 
p value 
F3 0.35 ± 0.06 0.39 ± 0.08 0.2909 
F4 0.38 ± 0.05 0.38 ± 0.08 0.8025 
F7 0.39 ± 0.06 0.40 ± 0.08 0.7425 
F8 0.39 ± 0.05 0.41 ± 0.07 0.5213 
Fp1 0.33 ± 0.09 0.39 ± 0.06 0.0730 
Fp2 0.33 ± 0.06 0.37 ± 0.09 0.2264 
T3 0.47 ± 0.09 0.48 ± 0.12 0.8449 
T4 0.48 ± 0.11 0.47 ± 0.10 0.8539 
T5 0.39 ± 0.08 0.46 ± 0.07 0.0236 
T6 0.38 ± 0.08 0.46 ± 0.08 0.0521 
C3 0.39 ± 0.08 0.43 ± 0.06 0.2166 
C4 0.41 ± 0.09 0.43 ± 0.05 0.4098 
P3* 0.35 ± 0.07 0.44 ± 0.05 0.0017 
P4 0.39 ± 0.07 0.44 ± 0.05 0.0124 
O1* 0.39 ± 0.07 0.49 ± 0.07 0.0056 
O2 0.39 ± 0.07 0.47 ± 0.08 0.0214 
Significant group differences are marked with an asterisk. 
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Table 3 
The average LZ Complexity (0-1-2 sequence conversion) values of the EEGs for the AD 
patients and control subjects for all channels.  
Electrode AD patients (Mean ± SD) 
Control subjects 
(Mean ± SD) 
Statistical analysis 
p value 
F3 0.33 ± 0.09 0.37 ± 0.08 0.2319 
F4 0.37 ± 0.06 0.37 ± 0.07 0.8442 
F7 0.36 ± 0.10 0.39 ± 0.07 0.3801 
F8 0.36 ± 0.09 0.40 ± 0.07 0.2324 
Fp1 0.29 ± 0.11 0.37 ± 0.08 0.0710 
Fp2 0.31 ± 0.07 0.38 ± 0.07 0.0500 
T3 0.44 ± 0.08 0.47 ± 0.10 0.4397 
T4 0.45 ± 0.09 0.45 ± 0.09 0.9735 
T5* 0.38 ± 0.06 0.45 ± 0.06 0.0072 
T6 0.35 ± 0.10 0.44 ± 0.07 0.0194 
C3 0.35 ± 0.11 0.42 ± 0.05 0.0810 
C4 0.33 ± 0.13 0.42 ± 0.04 0.0456 
P3* 0.33 ± 0.07 0.43 ± 0.04 0.0005 
P4* 0.34 ± 0.06 0.42 ± 0.05 0.0028 
O1* 0.38 ± 0.06 0.47 ± 0.06 0.0029 
O2 0.37 ± 0.06 0.45 ± 0.08 0.0225 
Significant group differences are marked with an asterisk.
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Table 4 
Test results for LZ complexity with both sequence conversion methods on the channels in 
which the differences between both groups were significant. The optimum threshold to 
discriminate AD patients and control subjects is included. 
LZ 
complexity 
sequence 
conversion 
Electrode Threshold Sensitivity Specificity Accuracy 
Area under 
the ROC 
curve 
0-1 P3 0.3995 72.7% 90.9% 81.8% 0.876 O1 0.4538 90.9% 72.7% 81.8% 0.851 
0-1-2 
P3 0.3962 81.8% 81.8% 81.8% 0.893 
P4 0.3485 72.7% 90.9% 81.8% 0.843 
O1 0.4411 90.9% 72.7% 81.8% 0.851 
T5 0.4160 72.7% 72.7% 72.7% 0.802 
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Figure legends 
Figure 1. Block diagram summarizing the steps followed in this study, from signal recording 
to the statistical analysis of the LZ complexity and CTM results. 
Figure 2. ROC curves for discriminating AD patients and control subjects with LZ complexity 
(0-1 sequence conversion) at the electrodes in which p < 0.01 (P3 and O1). The ROC curve is 
plotted using a dotted line, with its values marked with an asterisk. The interpolating parametric 
cubic spline curve is superimposed. (A) P3. (B) O1. 
Figure 3. ROC curves for discriminating AD patients and control subjects with LZ complexity 
(0-1-2 sequence conversion) at the electrodes in which p < 0.01 (P3, P4, O1 and T5). The 
ROC curve is plotted using a dotted line, with its values marked with an asterisk. The 
interpolating parametric cubic spline curve is superimposed. (A) P3. (B) P4. (C) O1. (D) T5. 
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